Connect Biopharma CNTB Stock
$2.30
-1.287553%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$144.84M
LOW - HIGH [24H]
$2.27
-
$2.40
VOLUME [24H]
$476.35K
P/E Ratio
0
Earnings per share
-$1.19
ISIN
KYG235491019
Connect Biopharma Price Chart
Connect Biopharma CNTB Financial and Trading Overview
| Connect Biopharma stock price | 2.3 USD |
| Previous Close | 2.36 USD |
| Open | 2.36 USD |
| Bid | 1.5 USD x 200 |
| Ask | 2.71 USD x 200 |
| Day's Range | 2.26 - 2.37 USD |
| 52 Week Range | 1.23 - 3.82 USD |
| Volume | 427.42K USD |
| Avg. Volume | 446.23K USD |
| Market Cap | 144.84M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.19 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.25 USD |
CNTB Valuation Measures
| Enterprise Value | 113.95M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.0831099 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 49.048733 |
| Price/Book (mrq) | 5.386417 |
| Enterprise Value/Revenue | 38.588 |
| Enterprise Value/EBITDA | -1.634 |
Trading Information
Connect Biopharma Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 32.94% |
| S&P500 52-Week Change | 18.35% |
| 52 Week High | 3.82 USD |
| 52 Week Low | 1.23 USD |
| 50-Day Moving Average | 2.24 USD |
| 200-Day Moving Average | 2.45 USD |
CNTB Share Statistics
| Avg. Volume (3 month) | 446.23K USD |
| Avg. Daily Volume (10-Days) | 450.04K USD |
| Shares Outstanding | 62.97M |
| Float | 21.07M |
| Short Ratio | 4.21 |
| % Held by Insiders | 29.67% |
| % Held by Institutions | 56.12% |
| Shares Short | 2.06M |
| Short % of Float | 4.63% |
| Short % of Shares Outstanding | 3.27% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -635.98% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -69.74% |
| Return on Equity (ttm) | -140.50% |
Income Statement
| Revenue (ttm) | 2.95M USD |
| Revenue Per Share (ttm) | 0.05 USD |
| Quarterly Revenue Growth (yoy) | 5666.69% |
| Gross Profit (ttm) | 2.95M USD |
| EBITDA | -69729000 USD |
| Net Income Avi to Common (ttm) | -68991000 USD |
| Diluted EPS (ttm) | -1.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 31.49M USD |
| Total Cash Per Share (mrq) | 0.5 USD |
| Total Debt (mrq) | 596K USD |
| Total Debt/Equity (mrq) | 2.22 USD |
| Current Ratio (mrq) | 2.369 |
| Book Value Per Share (mrq) | 0.427 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -60583000 USD |
| Levered Free Cash Flow (ttm) | -34712752 USD |
Profile of Connect Biopharma
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 3580 Carmel Mountain Road |
| ZIP | 92130 |
| Phone | 877 245 2787 |
| Website | https://www.connectbiopharm.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 64 |
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Q&A For Connect Biopharma Stock
What is a current CNTB stock price?
Connect Biopharma CNTB stock price today per share is 2.3 USD.
How to purchase Connect Biopharma stock?
You can buy CNTB shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Connect Biopharma?
The stock symbol or ticker of Connect Biopharma is CNTB.
Which industry does the Connect Biopharma company belong to?
The Connect Biopharma industry is Biotechnology.
How many shares does Connect Biopharma have in circulation?
The max supply of Connect Biopharma shares is 62.97M.
What is Connect Biopharma Price to Earnings Ratio (PE Ratio)?
Connect Biopharma PE Ratio is now.
What was Connect Biopharma earnings per share over the trailing 12 months (TTM)?
Connect Biopharma EPS is -1.19 USD over the trailing 12 months.
Which sector does the Connect Biopharma company belong to?
The Connect Biopharma sector is Healthcare.
Connect Biopharma CNTB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26447.99 USD — |
+1.22
|
4.72B USD — | 26273.87 USD — | 26553.9 USD — | — - | 4.72B USD — |
|
US Tech Global Market Composite
NQGM
US
|
2337.3 USD — |
+0.62
|
— — | 2329.25 USD — | 2344.13 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
7320.51 USD — |
-0.26
|
— — | 7281.04 USD — | 7346.52 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1368.89 USD — |
-0.28
|
— — | 1362.44 USD — | 1374.14 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
- {{ link.label }} {{link}}
